All stock lists
Evommune, Inc. (New York Stock Exchange:EVMN)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
5.26+0.16 (+3.14%)
Market cap
$191M
Health Score
Analyst consensus
Listed since
Nov 6, 2025
Website
Insider Score
––Not scored
EVMN Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
EVMN analyst forecast
EVMN analyst consensus
Moderate Buy3 ratings
Buy 2 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
EVMN 12-month price target
$19.67+280.3% upsideaverage of 3 firms
$30.00High
$8.00Low
Best analysts covering EVMN
No firm covering EVMN has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
EVMN analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| UBS | — | $8.00 | +28.0% | — | 2026-10-11 | |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2026-09-09 |
| RBC Capital | Outperform | $21.00 | +99.1% | Reiterated | 2026-09-09 | |
| — | Leerink Partners | Outperform | — | — | Reiterated | 2026-09-09 |
| Stifel Nicolaus | — | $30.00 | +174.9% | — | 2026-09-09 | |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-07 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2026-08-03 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-06-30 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2026-06-30 |
| — | William Blair | Market Perform | — | — | Downgraded | 2026-06-29 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-05-26 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-05-11 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-04-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-03-18 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-02-10 |
EVMN earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-05 | -0.82 | -1.43 | $722K | $0 |
| 2026-05-07 | -0.83 | -0.64 | $722K | $0 |
| 2026-08-06 | -0.66 | -0.89 | $1.3M | $0 |
| 2026-10-16 | -0.82 | 0.00 | $500K | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.